Atossa Therapeutics, Inc.(ATOWW)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATOWW Atossa Therapeutics, Inc.

交易中 01-22 14:20:00 EST 延时

{"stockData":{"symbol":"ATOWW","market":"US","secType":"STK","nameCN":"Atossa Therapeutics, Inc.","latestPrice":0.0004,"timestamp":1769109600000,"preClose":0.0004,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"01-22 14:20:00 EST 延时","open":0.0004,"high":0.0004,"low":0.0004,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1769115600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.0004,"volumeRatio":0},"requestUrl":"/m/hq/s/ATOWW","defaultTab":"news","newsList":[{"id":"2593175614","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大跌5.01%报0.681美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593175614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593175614?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:58","pubTimestamp":1766505485,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日23时58分，Atossa Therapeutics, Inc.股票出现波动，股价快速下挫5.01%。截至发稿，该股报0.681美元/股，成交量62.8961万股，换手率0.49%，振幅4.35%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，在肿瘤学领域未满足的医疗需求领域开发专有药物。该公司正在开发的用于治疗乳腺癌和其他乳腺疾病的药物是 Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122323580597a09c2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122323580597a09c2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","LENZ","ATOS","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2516654003","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654003?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:34","pubTimestamp":1741026843,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时34分，Atossa Therapeutics, Inc.股票出现异动，股价大幅下挫5.21%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4397.62%、193.93%、179.44%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023403a25d852a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023403a25d852a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2513212909","title":"Atossa Therapeutics, Inc.盘中异动 临近收盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513212909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513212909?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:45","pubTimestamp":1740170707,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时45分，Atossa Therapeutics, Inc.股票出现波动，股价快速跳水5.35%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044508962bc94e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044508962bc94e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","BK4139","ATOWW","LENZ"],"gpt_icon":0},{"id":"2512442484","title":"Atossa Therapeutics, Inc.盘中异动 临近午盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512442484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512442484?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:35","pubTimestamp":1739982914,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时35分，Atossa Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为588.87%、244.87%、198.65%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003514a24c12c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220003514a24c12c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","ATOS","BK4139","LENZ"],"gpt_icon":0},{"id":"2511834577","title":"Atossa Therapeutics, Inc.盘中异动 临近收盘股价大涨5.98%报0.815美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511834577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511834577?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:49","pubTimestamp":1739479792,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时49分，Atossa Therapeutics, Inc.股票出现异动，股价快速上涨5.98%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214044952988475a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214044952988475a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","ATOS","LENZ","BK4139"],"gpt_icon":0},{"id":"2510570356","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.82%报0.772美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510570356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510570356?lang=zh_cn&edition=full","pubTime":"2025-02-12 03:19","pubTimestamp":1739301549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日03时19分，Atossa Therapeutics, Inc.股票出现异动，股价急速跳水5.82%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.82%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120319099881eb56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120319099881eb56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOS","ATOWW","LENZ"],"gpt_icon":0},{"id":"2510377899","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.06%报0.804美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510377899?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:47","pubTimestamp":1739213269,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时47分，Atossa Therapeutics, Inc.股票出现异动，股价大幅上涨5.06%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211024749abc9dc2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211024749abc9dc2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","BK4139","ATOS","LENZ"],"gpt_icon":0},{"id":"2509977520","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.22%报0.763美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509977520","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509977520?lang=zh_cn&edition=full","pubTime":"2025-02-08 04:04","pubTimestamp":1738958641,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日04时04分，Atossa Therapeutics, Inc.股票出现波动，股价快速下跌5.22%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040401abc66ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208040401abc66ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","LENZ","ATOWW","BK4139"],"gpt_icon":0},{"id":"2509206797","title":"Atossa Therapeutics, Inc.盘中异动 股价大跌5.00%报0.807美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509206797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509206797?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:39","pubTimestamp":1738859962,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时39分，Atossa Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5854.40%、1533.54%、155.27%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Palatin Technologies, Inc.，振幅分别为125.58%、53.02%、49.54%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003922a23be9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207003922a23be9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2508528457","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508528457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508528457?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:40","pubTimestamp":1738680045,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时40分，Atossa Therapeutics, Inc.股票出现异动，股价大幅拉升5.05%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Azitra Inc、Evaxion Biotech As、Nutriband Inc C/Wts 涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1122.89%、764.82%、194.18%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Azitra Inc、Invivyd, Inc.，振幅分别为40.00%、38.71%、21.70%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224045a2392ab2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224045a2392ab2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ATOWW","ATOS"],"gpt_icon":0},{"id":"2507851961","title":"Atossa Therapeutics, Inc.盘中异动 大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507851961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507851961?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:39","pubTimestamp":1738334368,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时39分，Atossa Therapeutics, Inc.股票出现异动，股价急速拉升5.17%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1472.14%、334.79%、66.84%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Cyclerion Therapeutics, Inc.，振幅分别为62.40%、42.27%、32.28%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223928a23543c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223928a23543c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2507830621","title":"Atossa Therapeutics, Inc.股价重挫12.03% 市值跌1135.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507830621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507830621?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247477,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分，Atossa Therapeutics, Inc.股票出现异动，股价急速跳水12.03%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为583.70%、118.42%、93.09%，振幅较大的相关个股有Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Alterity Therapeutics Limited，振幅分别为17.92%、15.36%、10.65%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223117a23454d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223117a23454d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","ATOS","BK4139","LENZ"],"gpt_icon":0},{"id":"2506308418","title":"Atossa Therapeutics, Inc.盘中异动 急速下跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506308418?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988372,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Atossa Therapeutics, Inc.股票出现异动，股价快速下跌5.51%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Akero Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、89Bio, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为720.20%、41.56%、37.50%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Evaxion Biotech As、Tevogen Bio Holdings Inc.，振幅分别为37.50%、14.26%、14.07%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232529874af6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232529874af6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","LENZ","ATOS"],"gpt_icon":0},{"id":"2505729074","title":"Atossa Therapeutics, Inc.盘中异动 快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505729074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505729074?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:52","pubTimestamp":1737557523,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时52分，Atossa Therapeutics, Inc.股票出现异动，股价快速拉升5.17%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Immunoprecise Antibodies Ltd.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为634.09%、129.40%、58.64%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Scisparc Ltd.，振幅分别为47.48%、41.27%、26.07%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225203986f7b74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225203986f7b74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOS","ATOWW","BK4139"],"gpt_icon":0},{"id":"2505076742","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505076742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505076742?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:14","pubTimestamp":1737483250,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时14分，Atossa Therapeutics, Inc.股票出现波动，股价大幅拉升5.18%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.31%。其相关个股中，Camp4 Therapeutics Corporation、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为803.02%、514.11%、189.39%，振幅较大的相关个股有Channel Therapeutics Corporation、Camp4 Therapeutics Corporation、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为96.32%、46.97%、43.18%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122021410abb3766a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122021410abb3766a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOS","ATOWW","BK4139"],"gpt_icon":0},{"id":"2503685074","title":"Atossa Therapeutics, Inc.盘中异动 下午盘股价大跌5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503685074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503685074?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:00","pubTimestamp":1736884801,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时00分，Atossa Therapeutics, Inc.股票出现波动，股价大幅跳水5.72%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.03%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504000198663800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011504000198663800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOWW","ATOS","LENZ"],"gpt_icon":0},{"id":"2500142591","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500142591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500142591?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:44","pubTimestamp":1735915444,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时44分，Atossa Therapeutics, Inc.股票出现异动，股价快速拉升6.24%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大，Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为1013.42%、778.01%、271.37%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Cyclacel Pharmaceuticals, Inc.、Scorpius Holdings, Inc.，振幅分别为121.56%、76.84%、50.62%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224404a2146be8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103224404a2146be8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATOS","ATOWW","LENZ"],"gpt_icon":0},{"id":"2500649481","title":"Atossa Therapeutics, Inc.盘中异动 急速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500649481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500649481?lang=zh_cn&edition=full","pubTime":"2025-01-01 03:05","pubTimestamp":1735671925,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日03时05分，Atossa Therapeutics, Inc.股票出现波动，股价快速下跌5.01%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010103052595f464ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010103052595f464ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOS","ATOWW","BK4139","LENZ"],"gpt_icon":0},{"id":"2494382244","title":"Atossa Therapeutics, Inc.盘中异动 早盘股价大跌5.66%报1.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494382244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494382244?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:35","pubTimestamp":1735313754,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时35分，Atossa Therapeutics, Inc.股票出现异动，股价急速跳水5.66%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。该公司正在开发用于治疗乳腺癌和其他乳腺疾病的药物是Endoxifen。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233554a20c0c68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227233554a20c0c68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ATOWW","ATOS","BK4139"],"gpt_icon":0},{"id":"2493795288","title":"Atossa Therapeutics, Inc.盘中异动 股价大涨6.88%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493795288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493795288?lang=zh_cn&edition=full","pubTime":"2024-12-24 01:41","pubTimestamp":1734975702,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时41分，Atossa Therapeutics, Inc.股票出现波动，股价快速上涨6.88%。Atossa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为914.26%、870.67%、841.36%，振幅较大的相关个股有Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.，振幅分别为157.37%、104.19%、96.28%。Atossa Therapeutics, Inc.公司简介：Atossa Therapeutics Inc 是一家临床阶段的生物制药公司，致力于开发在肿瘤领域存在未满足医疗需求的专有创新药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224014143984d3e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224014143984d3e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATOWW","LENZ","ATOS","BK4139"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.7761},{"period":"3month","weight":-0.7761},{"period":"6month","weight":-0.7},{"period":"1year","weight":0.2},{"period":"ytd","weight":0.1538}],"exchange":"PINK","name":"Atossa Therapeutics, Inc.","nameEN":"Atossa Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atossa Therapeutics, Inc.(ATOWW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atossa Therapeutics, Inc.(ATOWW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atossa Therapeutics, Inc.,ATOWW,Atossa Therapeutics, Inc.股票,Atossa Therapeutics, Inc.股票老虎,Atossa Therapeutics, Inc.股票老虎国际,Atossa Therapeutics, Inc.行情,Atossa Therapeutics, Inc.股票行情,Atossa Therapeutics, Inc.股价,Atossa Therapeutics, Inc.股市,Atossa Therapeutics, Inc.股票价格,Atossa Therapeutics, Inc.股票交易,Atossa Therapeutics, Inc.股票购买,Atossa Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atossa Therapeutics, Inc.(ATOWW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atossa Therapeutics, Inc.(ATOWW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}